We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Molecular Diagnostics

Image: New findings connect ribosome stress biology with blood-based small RNA biomarkers, highlighting the potential of liquid biopsy for lung cancer patient stratification (Image credit: 123RF)

Blood-Based RNA Test May Predict Chemotherapy Sensitivity in Lung Cancer

New findings link ribosome quality control to liquid-biopsy small RNAs, enabling lung cancer stratification and therapy guidance. More...
10 Jun 2026
Image: A simple blood test could help identify which patients with head and neck cancer are most likely to benefit from immunotherapy (image credit: Adobe Stock)

Blood Test Predicts Immunotherapy Response in Head and Neck Cancer

A blood-based cfDNA fragment test predicts pre-treatment immunotherapy response in head and neck cancer, outperforming biomarkers. More...
09 Jun 2026
Image: Roche developed a research-use PCR assay within six days of the Bundibugyo virus genome sequence being published (image credit: Adobe Stock)

New PCR Assay Supports Bundibugyo Ebola Outbreak Surveillance

A new research-use PCR test detects Bundibugyo virus to support faster outbreak response. More...
08 Jun 2026
Image: The Deep Visual Spatial Transcriptomics and Proteomics (DVSTP) strategy integrates high-resolution pathology images with spatial transcriptomics and spatial proteomics to reveal the complex intra-tumor heterogeneity. DVSTP predicts molecular profiles from routine pathology slides, making spatial multi-omics more accessible. Whole–tumor 3D reconstruction reveals that SRSF6 drives immune exclusion and poor clinical outcomes (Photo courtesy of Science Bulletin)

AI-Enabled Spatial Multi-Omics Maps Colorectal Tumor Architecture

An AI–enabled, 3D spatial multi-omics strategy delineates colorectal tumor architecture and immune infiltration. More...
06 Jun 2026
Image: Graphical abstract (Pandya T, Zagorulya M, Leung MM, et al. Plasma signals of lung tumor promotion for molecular cancer prevention. Cell. 2026. doi:10.1016/j.cell.2026.05.005)

Plasma Protein Signature Predicts Lung Cancer Risk Up to Five Years Ahead

A 14-protein blood signature predicts lung cancer risk up to five years before diagnosis, beyond smoking status. More...
05 Jun 2026
Image: New findings show that circulating tumor DNA testing can guide postoperative chemotherapy and reduce relapse in selected patients (Image credit: Shutterstock)

Circulating Tumor DNA Testing Guides Chemotherapy, Reduces Relapse in Colon Cancer

A ctDNA blood test guides adjuvant chemotherapy in stage II colon cancer and cuts relapse risk. More...
04 Jun 2026
Image: In ALT-positive cancers, researchers found that centromere-associated DNA can be inserted near telomeres at chromosome ends (Image credit: Shutterstock)

Researchers Uncover Distinct Chromosome Signature in Aggresive ALT Cancers

New findings reveal a previously unseen chromosome interaction in alternative lengthening of telomeres positive (ALT+) tumors More...
04 Jun 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Automated Clinical Chemistry Analyzer
Envoy 500+
Hematology Consumables
Bioblood Devices


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.